Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton

Journal of Virology

Volumn 83, Issue 14, 2009, Pages 7015-7028

  Miller, Matthew S ^a   Hertel, Laura ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NEF PROTEIN; PROTEIN KINASE LCK; PROTEIN P56;

ARTICLE; BONE MARROW CULTURE; ENDOCYTOSIS; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; VIRUS CELL INTERACTION;

ANIMALS; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOSKELETON; FIBROBLASTS; HUMANS; INTERMEDIATE FILAMENTS; MICE; VIMENTIN; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5; MIRIDAE; MUS;

EID: 67650424329     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00398-09     Document Type: Article

References (96)

1. Adler, B., L. Scrivano, Z. Ruzcics, B. Rupp, C. Sinzger, and U. Koszinowski. 2006. Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J. Gen. Virol. 87:2451-2460.
2. Aggeler, J., and K. Seely. 1990. Cytoskeletal dynamics in rabbit synovial fibroblasts. I. Effects of acrylamide on intermediate filaments and microfilaments. Cell Motil. Cytoskeleton 16:110-120.
3. Akter, P., C. Cunningham, B. P. McSharry, A. Dolan, C. Addison, D. J. Dargan, A. F. Hassan-Walker, V. C. Emery, P. D. Griffiths, G. W. Wilkinson, and A. J. Davison. 2003. Two novel spliced genes in human cytomegalovirus. J. Gen. Virol. 84:1117-1122.
4. Arcangeletti, M. C., F. Pinardi, M. C. Medici, E. Pilotti, F. De Conto, F. Ferraglia, M. P. Landini, C. Chezzi, and G. Dettori. 2000. Cytoskeleton involvement during human cytomegalovirus replicative cycle in human embryo fibroblasts. New Microbiol. 23:241-256.
5. Belin, M. T., and P. Boulanger. 1985. Cytoskeletal proteins associated with intracytoplasmic human adenovirus at an early stage of infection. Exp. Cell Res. 160:356-370.
6. Belin, M. T., and P. Boulanger. 1987. Processing of vimentin occurs during the early stages of adenovirus infection. J. Virol. 61:2559-2566.
7. Bhattacharya, B., R. J. Noad, and P. Roy. 2007. Interaction between Blue-tongue virus outer capsid protein VP2 and vimentin is necessary for virus egress. Virol. J. 4:7.
8. Britt, W. 2008. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 325:417-470.
9. Buss, F., G. Spudich, and J. Kendrick-Jones. 2004. Myosin VI: cellular functions and motor properties. Annu. Rev. Cell Dev. Biol. 20:649-676.
10. Capco, D. G., K. M. Wan, and S. Penman. 1982. The nuclear matrix: three-dimensional architecture and protein composition. Cell 29:847-858.
11. Cha, T. A., E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R. Spaete. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
12. Chang, L., and R. D. Goldman. 2004. Intermediate filaments mediate cytoskeletal crosstalk. Nat. Rev. Mol. Cell Biol. 5:601-613.
13. Chen, W., N. Gao, J. L. Wang, Y. P. Tian, Z. T. Chen, and J. An. 2008. Vimentin is required for dengue virus serotype 2 infection but microtubules are not necessary for this process. Arch. Virol. 153:1777-1781.
14. Clement, C., V. Tiwari, P. M. Scanlan, T. Valyi-Nagy, B. Y. Yue, and D. Shukla. 2006. A novel role for phagocytosis-like uptake in herpes simplex virus entry. J. Cell Biol. 174:1009-1021.
15. Colucci-Guyon, E., M. M. Portier, I. Dunia, D. Paulin, S. Pournin, and C. Babinet. 1994. Mice lacking vimentin develop and reproduce without an obvious phenotype. Cell 79:679-694.
16. Compton, T., R. R. Nepomuceno, and D. M. Nowlin. 1992. Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 191:387-395.
17. Compton, T., D. M. Nowlin, and N. R. Cooper. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193:834-841.
18. Cordo, S. M., and N. A. Candurra. 2003. Intermediate filament integrity is required for Junin virus replication. Virus Res. 97:47-55.
19. Ding, J., E. Allen, W. Wang, A. Valle, C. Wu, T. Nardine, B. Cui, J. Yi, A. Taylor, N. L. Jeon, S. Chu, Y. So, H. Vogel, R. Tolwani, W. Mobley, and Y. Yang. 2006. Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Hum. Mol. Genet. 15:1451-1463.
20. Durham, H. D., S. D. Pena, and S. Carpenter. 1983. The neurotoxins 2,5-hexanedione and acrylamide promote aggregation of intermediate filaments in cultured fibroblasts. Muscle Nerve 6:631-637.
21. Eckert, B. S. 1985. Alteration of intermediate filament distribution in PtK1 cells by acrylamide. Eur. J. Cell Biol. 37:169-174.
22. Elek, S. D., and H. Stern. 1974. Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero. Lancet 1:1-5.
23. Feire, A. L., H. Koss, and T. Compton. 2004. Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl. Acad. Sci. USA 101:15470-15475.
24. Ferreira, L. R., N. Moussatche, and V. Moura Neto. 1994. Rearrangement of intermediate filament network of BHK-21 cells infected with vaccinia virus. Arch. Virol. 138:273-285.
25. Franke, W. W., E. Schmid, M. Osborn, and K. Weber. 1978. Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc. Natl. Acad. Sci. USA 75:5034-5038.
26. Gao, Y., and E. Sztul. 2001. A novel interaction of the Golgi complex with the vimentin intermediate filament cytoskeleton. J. Cell Biol. 152:877-894.
27. Garcia-Barreno, B., J. L. Jorcano, T. Aukenbauer, C. Lopez-Galindez, and J. A. Melero. 1988. Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV). Virus Res. 9:307-321.
28. Gawlitta, W., M. Osborn, and K. Weber. 1981. Coiling of intermediate filaments induced by microinjection of a vimentin-specific antibody does not interfere with locomotion and mitosis. Eur. J. Cell Biol. 26:83-90.
29. Gillard, B. K., R. Clement, E. Colucci-Guyon, C. Babinet, G. Schwarzmann, T. Taki, T. Kasama, and D. M. Marcus. 1998. Decreased synthesis of glycosphingolipids in cells lacking vimentin intermediate filaments. Exp. Cell Res. 242:561-572.
30. Goldman, R. D. 1971. The role of three cytoplasmic fibers in BHK-21 cell motility. I. Microtubules and the effects of colchicine. J. Cell Biol. 51:752-762.
31. Greber, U. F., and M. Way. 2006. A superhighway to virus infection. Cell 124:741-754.
32. Hahn, G., M. G. Revello, M. Patrone, E. Percivalle, G. Campanini, A. Sarasini, M. Wagner, A. Gallina, G. Milanesi, U. Koszinowski, F. Baldanti, and G. Gerna. 2004. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol. 78:10023-10033.
33. Hay, M., and U. De Boni. 1991. Chromatin motion in neuronal interphase nuclei: changes induced by disruption of intermediate filaments. Cell Motil. Cytoskeleton. 18:63-75.
34. Herman, B., and D. F. Albertini. 1982. The intracellular movement of endocytic vesicles in cultured granulosa cells. Cell Motil. 2:583-597.
35. Hertel, L., V. G. Lacaille, H. Strobl, E. D. Mellins, and E. S. Mocarski. 2003. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J. Virol. 77:7563-7574.
36. Hertel, L., and E. S. Mocarski. 2004. Global analysis of host cell gene expression late during cytomegalovirus infection reveals extensive dysregulation of cell cycle gene expression and induction of pseudomitosis independent of US28 function. J. Virol. 78:11988-12011.
37. Hobom, U., W. Brune, M. Messerle, G. Hahn, and U. H. Koszinowski. 2000. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J. Virol. 74:7720-7729.
38. Isaacson, M. K., A. L. Feire, and T. Compton. 2007. Epidermal growth factor receptor is not required for human cytomegalovirus entry or signaling. J. Virol. 81:6241-6247.
39. Isaacson, M. K., L. K. Juckem, and T. Compton. 2008. Virus entry and innate immune activation. Curr. Top. Microbiol. Immunol. 325:85-100.
40. Ivaska, J., H. M. Pallari, J. Nevo, and J. E. Eriksson. 2007. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp. Cell Res. 313:2050-2062.
41. Ivaska, J., K. Vuoriluoto, T. Huovinen, I. Izawa, M. Inagaki, and P. J. Parker. 2005. PKε-mediated phosphorylation of vimentin controls integrin recycling and motility. EMBO J. 24:3834-3845.
42. Jones, N. L., J. C. Lewis, and B. A. Kilpatrick. 1986. Cytoskeletal disruption during human cytomegalovirus infection of human lung fibroblasts. Eur. J. Cell Biol. 41:304-312.
43. Kamei, H. 1994. Relationship of nuclear invaginations to perinuclear rings composed of intermediate filaments in MIA PaCa-2 and some other cells. Cell Struct. Funct. 19:123-132.
44. Kim, J. K., A. M. Fahad, K. Shanmukhappa, and S. Kapil. 2006. Defining the cellular target(s) of porcine reproductive and respiratory syndrome virus blocking monoclonal antibody 7G10. J. Virol. 80:689-696.
45. Kinzler, E. R., R. N. Theiler, and T. Compton. 2002. Expression and reconstitution of the gH/gL/gO complex of human cytomegalovirus. J. Clin. Virol. 25(Suppl. 2):S87-S95.
46. Klymkowsky, M. W. 1981. Intermediate filaments in 3T3 cells collapse after intracellular injection of a monoclonal anti-intermediate filament antibody. Nature 291:249-251.
47. Klymkowsky, M. W. 1988. Metabolic inhibitors and intermediate filament organization in human fibroblasts. Exp. Cell Res. 174:282-290.
48. Klymkowsky, M. W., and D. J. Plummer. 1985. Giant axonal neuropathy: a conditional mutation affecting cytoskeletal organization. J. Cell Biol. 100:245-250.
49. LaFemina, R. L., and G. S. Hayward. 1988. Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus. J. Gen. Virol. 69:355-374.
50. LaFemina, R. L., and G. S. Hayward. 1983. Replicative forms of human cytomegalovirus DNA with joined termini are found in permissively infected human cells but not in non-permissive Balb/c-3T3 mouse cells. J. Gen. Virol. 64:373-389.
51. Leung, C. L., Y. Pang, C. Shu, D. Goryunov, and R. K. Liem. 2007. Alterations in lipid metabolism gene expression and abnormal lipid accumulation in fibroblast explants from giant axonal neuropathy patients. BMC Genet. 8:6.
52. Lieber, J. G., and R. M. Evans. 1996. Disruption of the vimentin intermediate filament system during adipose conversion of 3T3-L1 cells inhibits lipid droplet accumulation. J. Cell Sci. 109:3047-3058.
53. Lin, J. J., and J. R. Feramisco. 1981. Disruption of the in vivo distribution of the intermediate filaments in fibroblasts through the microinjection of a specific monoclonal antibody. Cell 24:185-193.
54. Losse, D., R. Lauer, D. Weder, and K. Radsak. 1982. Actin distribution and synthesis in human fibroblasts infected by cytomegalovirus. Arch. Virol. 71:353-359.
55. Lyman, M. G., and L. W. Enquist. 2009. Herpesvirus interactions with the host cytoskeleton. J. Virol. 83:2058-2066.
56. Maniotis, A. J., C. S. Chen, and D. E. Ingber. 1997. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc. Natl. Acad. Sci. USA 94:849-854.
57. Marsh, M., and A. Helenius. 2006. Virus entry: open sesame. Cell 124:729-740.
58. Mocarski, E. S., T. Shenk, and R. F. Pass. 2007. Cytomegaloviruses, p. 2701-2772. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
59. Murphy, E., and T. Shenk. 2008. Human cytomegalovirus genome. Curr. Top. Microbiol. Immunol. 325:1-19.
60. Murti, K. G., and R. Goorha. 1983. Interaction of frog virus-3 with the cytoskeleton. I. Altered organization of microtubules, intermediate filaments, and microfilaments. J. Cell Biol. 96:1248-1257.
61. Murti, K. G., R. Goorha, and M. W. Klymkowsky. 1988. A functional role for intermediate filaments in the formation of frog virus 3 assembly sites. Virology 162:264-269.
62. Nedellec, P., P. Vicart, C. Laurent-Winter, C. Martinat, M. C. Prevost, and M. Brahic. 1998. Interaction of Theiler's virus with intermediate filaments of infected cells. J. Virol. 72:9553-9560.
63. Norrild, B., V. P. Lehto, and I. Virtanen. 1986. Organization of cytoskeleton elements during herpes simplex virus type 1 infection of human fibroblasts: an immunofluorescence study. J. Gen. Virol. 67:97-105.
64. Ogawa-Goto, K., K. Tanaka, W. Gibson, E. Moriishi, Y. Miura, T. Kurata, S. Irie, and T. Sata. 2003. Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid. J. Virol. 77:8541-8547.
65. Olink-Coux, M., M. Huesca, and K. Scherrer. 1992. Specific types of prosomes are associated to subnetworks of the intermediate filaments in PtK1 cells. Eur. J. Cell Biol. 59:148-159.
66. Patrone, M., M. Secchi, E. Bonaparte, G. Milanesi, and A. Gallina. 2007. Cytomegalovirus UL131-128 products promote gB conformational transition and gB-gH interaction during entry into endothelial cells. J. Virol. 81:11479-11488.
67. Pena, S. D. 1981. Giant axonal neuropathy: intermediate filament aggregates in cultured skin fibroblasts. Neurology 31:1470-1473.
68. Plotkin, S. A., T. Furukawa, N. Zygraich, and C. Huygelen. 1975. Candidate cytomegalovirus strain for human vaccination. Infect. Immun. 12:521-527.
69. Potokar, M., M. Kreft, L. Li, J. Daniel Andersson, T. Pangrsic, H. H. Chowdhury, M. Pekny, and R. Zorec. 2007. Cytoskeleton and vesicle mobility in astrocytes. Traffic 8:12-20.
70. Prahlad, V., M. Yoon, R. D. Moir, R. D. Vale, and R. D. Goldman. 1998. Rapid movements of vimentin on microtubule tracks: kinesin-dependent assembly of intermediate filament networks. J. Cell Biol. 143:159-170.
71. Radtke, K., K. Dohner, and B. Sodeik. 2006. Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell. Cell Microbiol. 8:387-400.
72. Risco, C., J. R. Rodriguez, C. Lopez-Iglesias, J. L. Carrascosa, M. Esteban, and D. Rodriguez. 2002. Endoplasmic reticulum-Golgi intermediate compartment membranes and vimentin filaments participate in vaccinia virus assembly. J. Virol. 76:1839-1855.
73. Ryckman, B. J., M. A. Jarvis, D. D. Drummond, J. A. Nelson, and D. C. Johnson. 2006. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J. Virol. 80:710-722.
74. Ryckman, B. J., B. L. Rainish, M. C. Chase, J. A. Borton, J. A. Nelson, M. A. Jarvis, and D. C. Johnson. 2008. Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J. Virol. 82:60-70.
75. Sager, P. R. 1989. Cytoskeletal effects of acrylamide and 2,5-hexanedione: selective aggregation of vimentin filaments. Toxicol. Appl. Pharmacol. 97:141-155.
76. Sarria, A. J., J. G. Lieber, S. K. Nordeen, and R. M. Evans. 1994. The presence or absence of a vimentin-type intermediate filament network affects the shape of the nucleus in human SW-13 cells. J. Cell Sci. 107:1593-1607.
77. Sharpe, A. H., L. B. Chen, and B. N. Fields. 1982. The interaction of mammalian reoviruses with the cytoskeleton of monkey kidney CV-1 cells. Virology 120:399-411.
78. Shoeman, R. L., C. Huttermann, R. Hartig, and P. Traub. 2001. Amino-terminal polypeptides of vimentin are responsible for the changes in nuclear architecture associated with human immunodeficiency virus type 1 protease activity in tissue culture cells. Mol. Biol. Cell 12:143-154.
79. Sinzger, C. 2008. Entry route of HCMV into endothelial cells. J. Clin. Virol. 41:174-179.
80. Sinzger, C., M. Digel, and G. Jahn. 2008. Cytomegalovirus cell tropism. Curr. Top. Microbiol. Immunol. 325:63-83.
81. Sinzger, C., M. Kahl, K. Laib, K. Klingel, P. Rieger, B. Plachter, and G. Jahn. 2000. Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J. Gen. Virol. 81:3021-3035.
82. Slobbe-van Drunen, M. E., A. T. Hendrickx, R. C. Vossen, E. J. Speel, M. C. van Dam-Mieras, and C. A. Bruggeman. 1998. Nuclear import as a barrier to infection of human umbilical vein endothelial cells by human cytomegalovirus strain AD169. Virus Res. 56:149-156.
83. Smith, J. D., and E. de Harven. 1974. Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. II. An ultrastructural study of viral penetration. J. Virol. 14:945-956.
84. Soroceanu, L., A. Akhavan, and C. S. Cobbs. 2008. Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection. Nature 455:391-395.
85. Stefanovic, S., M. Windsor, K. I. Nagata, M. Inagaki, and T. Wileman. 2005. Vimentin rearrangement during African swine fever virus infection involves retrograde transport along microtubules and phosphorylation of vimentin by calcium calmodulin kinase II. J. Virol. 79:11766-11775.
86. Styers, M. L., A. P. Kowalczyk, and V. Faundez. 2005. Intermediate filaments and vesicular membrane traffic: the odd couple's first dance? Traffic 6:359-365.
87. Styers, M. L., G. Salazar, R. Love, A. A. Peden, A. P. Kowalczyk, and V. Faundez. 2004. The endo-lysosomal sorting machinery interacts with the intermediate filament cytoskeleton. Mol. Biol. Cell 15:5369-5382.
88. Thomas, E. K., R. J. Connelly, S. Pennathur, L. Dubrovsky, O. K. Haffar, and M. I. Bukrinsky. 1996. Anti-idiotypic antibody to the V3 domain of gp120 binds to vimentin: a possible role of intermediate filaments in the early steps of HIV-1 infection cycle. Viral Immunol. 9:73-87.
89. Tolstonog, G. V., E. Mothes, R. L. Shoeman, and P. Traub. 2001. Isolation of SDS-stable complexes of the intermediate filament protein vimentin with repetitive, mobile, nuclear matrix attachment region, and mitochondrial DNA sequence elements from cultured mouse and human fibroblasts. DNA Cell Biol. 20:531-554.
90. Traub, P. 1995. Intermediate filaments and gene regulation. Physiol. Chem. Phys Med. NMR 27:377-400.
91. Walter, I., and N. Nowotny. 1999. Equine herpes virus type 1 (EHV-1) infection induces alterations in the cytoskeleton of Vero cells but not apoptosis. Arch. Virol. 144:1827-1836.
92. Wang, D., and T. Shenk. 2005. Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J. Virol. 79:10330-10338.
93. Wang, D., and T. Shenk. 2005. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. USA 102:18153-18158.
94. Wang, X., D. Y. Huang, S. M. Huong, and E. S. Huang. 2005. Integrin αvβ3 is a coreceptor for human cytomegalovirus. Nat. Med. 11:515-521.
95. Wang, X., S. M. Huong, M. L. Chiu, N. Raab-Traub, and E. S. Huang. 2003. Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 424:456-461.
96. Yang, Y., E. Allen, J. Ding, and W. Wang. 2007. Giant axonal neuropathy. Cell Mol. Life Sci. 64:601-609.